Dendreon seeks OK for Provenge
13th Nov 2006, 19:47 GMT
Dendreon said Monday it completed its biologics license application for Provenge to the U.S. Food and Drug Administration.
Dendreon seeks OK for Provenge related news:
- Dendreon Completes Submission of Biologics License Application to FDA for PROVENGE in Hormone Refractory Prostate Cancer — Government/ Industry Regulation News from StratCenter.com
- Dendreon Asks FDA to OK Prostate Drug — Government/ Industry Regulation News from StratCenter.com
- Dendreon completes FDA filing for prostate-cancer drug — The Seattle Times: Horse racing
- Investing: Deutsche Bank seeks millionaires of China — Marketplace by Bloomberg - International Herald Tribune
- Dupas seeks trial delay — NEWS.com.au | The Nation
- Greensboro Seeks Input On Police Chief Search — WXII12.com - Local News
- Covington Mayor seeks splash — Cincinnati Enquirer - Top Stories
- Navy Seeks Public Comments On Sonar Training — NBC 17 - Local News
- Buffett's Berkshire seeks power deals — Financial news of the day - CNNMoney.com
- Czech Premier seeks a political deal with rival Social Democrats — Prague TV's Daily News Headlines
Latest news from United Press International - Health Business:
- AmerisourceBergen tests Rx tracking plan
- Lilly: Arxxant cuts sight loss in diabetes
- Merck: Arcoxia heart risk same as Voltaren
- Corcept tests psych. major depression Rx
- Neurogen's obesity drug in phase 1 trial
- Analysis: Insurance horizons expanding
- Robots caring for stroke patients
- Diabetes drug stalls heart disease
- Diabetes drug also helps arteries
- Promising vaccine for early breast cancer